• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

How not to run a sin­gle-arm tri­al: EMA high­lights more than a dozen 'bi­as­es' — and ways to mit­i­gate them

3 years ago
Pharma

Apel­lis’ ex­pan­sion plans in­to ALS face road­block

3 years ago
R&D

Lil­ly, No­vo Nordisk, Sanofi CEOs to face off with Bernie Sander­s' health com­mit­tee in May

3 years ago
People
Pharma

Roche’s Genen­tech de­buts first con­sumer ef­fort for di­a­betes and age-re­lat­ed eye dis­ease drug

3 years ago
Pharma
Marketing

SK Life Sci­ence sets up an in­door rain­storm to point to its an­ti-seizure drug Xco­pri's full cov­er­age

3 years ago
Pharma
Marketing

'We want to car­ry them al­l': Mark Cuban on why trans­paren­cy is king when it comes to drug prices

3 years ago
Pharma

An­a­lysts ex­pect qui­et first quar­ter as Big Phar­ma earn­ings be­gin to roll in

3 years ago
R&D

Phar­maEssen­tia se­cures $462M+ to fur­ther growth of Besre­mi and its pipeline

3 years ago
Financing
R&D

Ocuphire CEO says her post was ter­mi­nat­ed with no cause giv­en

3 years ago
People

Ac­tivist in­vestor push­es Bay­er to sep­a­rate crop sci­ence, con­sumer health from phar­ma

3 years ago
Pharma

FDA push­es back PDU­FA date for Dai­ichi's AML drug quizar­tinib over REMS up­dates

3 years ago
FDA+

Chi­nese biotech start­up adds $315M to the bank af­ter bring­ing 5 Take­da drugs to its fold

3 years ago
Financing
China

Jun­shi Bio­sciences touts lung can­cer da­ta as it looks to ex­pand PD-1 la­bel in Chi­na again

3 years ago
R&D

Amy­lyx wel­comes for­mer Al­ny­lam ex­ec to help ex­pand Re­lyvrio; Amarin plugs in an in­ter­im chief

3 years ago
Peer Review

Fed­er­al ap­peals court bars gener­ics for Ote­zla un­til 2028

3 years ago
Pharma
Law

Bausch Health’s Sal­ix spot­lights liv­er dis­ease in­di­ca­tion for Xi­fax­an

3 years ago
Pharma
Marketing

Bi­par­ti­san PBM re­forms take root in Sen­ate Fi­nance Com­mit­tee

3 years ago
Pharma
Law

Out­go­ing reg­u­la­to­ry chief de­tails hir­ing and re­ten­tion chal­lenges for FDA in­spec­tors

3 years ago
FDA+
Manufacturing

Man­u­fac­tur­ing roundup: Aji­nomo­to gets FDA ap­proval for man­u­fac­tur­ing line; PCI Phar­ma fill ma­chines come on­line

3 years ago
Manufacturing

KBI Bio­phar­ma and Se­lex­is hire J.D. Mow­ery as new CEO

3 years ago
People
Pharma

Astel­las and Twist team up in an­ti­bod­ies; FDA asks DBV for an ad­di­tion­al safe­ty study in peanut al­ler­gy patch

3 years ago
News Briefing

Mod­er­na, IBM turn to quan­tum com­put­ing in hunt for new mR­NA med­i­cines

3 years ago
Deals
AI

BeiGene notch­es win for PD-1 drug in stom­ach can­cers. When will part­ner No­var­tis sub­mit for ap­proval?

3 years ago
R&D

Ha­le­on’s Ex­cedrin brand ad­vo­cates no-drug ap­proach in ‘Head Care’ cam­paign with celebri­ty dancer

3 years ago
Pharma
Marketing
First page Previous page 352353354355356357358 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times